What did @loseitwithannie actually say?
She's 24 hours post-injection and feeling rough. Fatigue, headache, general misery. Her advice: time your shot before a free weekend so you can rest if needed. Her main point is that "even people on maintenance who've been on this medication for 20 months can have side effects." She also lists what she tried to manage symptoms: hydration, electrolytes, papaya enzymes, and ibuprofen.
This is a firsthand account, not a medical recommendation. She's not telling you what dose to take or claiming tirzepatide cures anything. She's documenting a bad day and sharing a scheduling tip. That's a pretty narrow lane, and she mostly stays in it.
Does the science back this up?
Yes, the core claim holds. Side effects on GLP-1 and GIP/GLP-1 receptor agonists like tirzepatide are not a new-user-only problem. The evidence says so plainly.
The SURMOUNT-1 trial (Jastreboff et al., 2022, NEJM) followed patients on tirzepatide for 72 weeks. Gastrointestinal adverse events were most common early but were still reported throughout the trial at all dose levels, including in participants who had been on stable doses for months. The trial did not suggest these effects resolve permanently after a titration period.
A 2023 real-world analysis published in Diabetes, Obesity and Metabolism (Blonde et al.) confirmed that nausea, fatigue, and headache remain reported adverse events even in long-term users. Intermittent flare-ups, not a clean plateau, appear to be the more accurate picture for a meaningful subset of patients.
Her scheduling advice, doing the injection before days when you can rest, is consistent with how many clinicians informally counsel patients. It is not an FDA recommendation, but it is reasonable harm-reduction logic.
What did they get wrong (or right)?
She got the main claim right. Long-term users can still have symptomatic days. That is accurate and worth saying out loud given how often the narrative online is "side effects go away after a few weeks."
The papaya enzyme recommendation deserves a closer look. Papain, the active enzyme in papaya supplements, is sometimes promoted for digestive discomfort, but there is no clinical evidence supporting its use specifically for GLP-1-related nausea or gastroparesis-adjacent symptoms. It is not dangerous for most people, but it is also not studied in this context. She presents it as part of her personal toolkit without claiming it is proven, which is a fair framing. Still, viewers may assume it is evidence-based when it is not.
Ibuprofen use on an empty or near-empty stomach, which is common when GLP-1 users are nauseated and eating little, carries real GI irritation risk. She does not mention this. It is a minor omission but worth noting for anyone following her routine.
What should you actually know?
Side effects from tirzepatide are not a one-time hurdle you clear during titration. For some patients, they resurface when doses are adjusted, when eating habits change, or seemingly at random. The SURMOUNT program data and post-market reporting both confirm this.
If you are managing side effects, the interventions with the most clinical support are small, low-fat meals, staying upright after eating, and staying hydrated. Electrolytes have indirect support through hydration management. Papaya enzymes and similar supplements do not have peer-reviewed backing for this specific use case.
NSAIDs like ibuprofen are worth using cautiously if you are already experiencing nausea or eating very little. Acetaminophen is generally considered the lower-risk option in that scenario. Talk to your prescriber before making that call.
Her broader point, that being on maintenance dose does not make you immune to hard days - is accurate, not alarmist, and more honest than a lot of content in this space.